{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:33:14Z","timestamp":1793377994631,"version":"4.5.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.108926","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T05:46:52Z","timestamp":1780811212000},"page":"108926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Musculoskeletal adverse effects associated with inhaled levofloxacin in a patient with cystic fibrosis: A case report"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9518-6298","authenticated-orcid":false,"given":"Sayed","family":"Alwadaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0476-2700","authenticated-orcid":false,"given":"Nicki","family":"Allsup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejene","family":"Shiferaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmed.2026.108926_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jcf.2015.12.004","article-title":"Efficacy and safety of inhaled levofloxacin in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Flume","year":"2016","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2026.108926_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jcf.2014.12.013","article-title":"Levofloxacin inhalation solution (LIS) versus tobramycin inhalation solution (TIS) in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection: a randomized study","volume":"14","author":"Elborn","year":"2015","journal-title":"J. Cyst. Fibros."},{"issue":"1","key":"10.1016\/j.rmed.2026.108926_bib3","first-page":"135","article-title":"Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1\u03b2 in human tendon-derived cells: a potential mechanism of fluoroquinolone-induced tendinopathy","volume":"21","author":"Corps","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.rmed.2026.108926_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jor.21196","article-title":"Fluoroquinolone-associated tendinopathy and tendon rupture: a review of the literature","volume":"29","author":"Tsai","year":"2011","journal-title":"J. Orthop. Res."},{"issue":"3","key":"10.1016\/j.rmed.2026.108926_bib5","first-page":"e20","article-title":"Real-world safety and effectiveness of inhaled levofloxacin in cystic fibrosis patients","volume":"20","author":"Schwarz","year":"2021","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.rmed.2026.108926_bib6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.01744-10","article-title":"Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in patients with cystic fibrosis","volume":"55","author":"Geller","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.rmed.2026.108926_bib7","first-page":"1","article-title":"Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects","volume":"12","year":"2019","journal-title":"Drug Safety Update"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:37:29Z","timestamp":1793374649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":7,"alternative-id":["S0954611126002945"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108926","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Musculoskeletal adverse effects associated with inhaled levofloxacin in a patient with cystic fibrosis: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108926"}}